Get the Stockscreener App
4.65
3.93%
-0.19
After Hours:
4.71
0.06
+1.29%
Goodrx Holdings Inc stock is traded at $4.65, with a volume of 1.53M.
It is down -3.93% in the last 24 hours and down -6.06% over the past month.
GoodRx Holdings Inc is a consumer-focused digital healthcare platform that aims to lower the cost of healthcare in the United States. It operates a price comparison platform that provides consumers with curated, geographically relevant prescription pricing, and provides access to negotiated prices through codes that can be used to save money on prescriptions across the United States. GoodRx generates revenue from core business from pharmacy benefit managers (PBMs) that manage formularies and prescription transactions including establishing pricing between consumers and pharmacies. It also offers various healthcare products and services, including pharma manufacturer solutions, subscriptions, and telehealth services.
See More
Previous Close:
$4.84
Open:
$4.85
24h Volume:
1.53M
Relative Volume:
1.27
Market Cap:
$1.77B
Revenue:
$775.09M
Net Income/Loss:
$-58.68M
P/E Ratio:
-35.07
EPS:
-0.1326
Net Cash Flow:
$64.06M
1W Performance:
-8.46%
1M Performance:
-6.06%
6M Performance:
-43.50%
1Y Performance:
-27.12%
1-Day Range:
$4.545
$4.93
1-Week Range:
$4.545
$5.25
52-Week Range:
$4.09
$9.2599
Goodrx Holdings Inc Stock (GDRX) Company Profile
Name
Goodrx Holdings Inc
Sector
Industry
Phone
(855) 268-2822
Address
2701 OLYMPIC BOULEVARD, SANTA MONICA
Compare GDRX with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
GDRX
Goodrx Holdings Inc
|
4.65 | 1.77B | 775.09M | -58.68M | 64.06M | -0.1326 |
|
VEEV
Veeva Systems Inc
|
221.36 | 35.94B | 2.66B | 665.91M | 1.08B | 4.05 |
|
SOLV
Solventum Corp
|
83.56 | 14.44B | 8.26B | 66.00M | 1.17B | 0.3682 |
|
DOCS
Doximity Inc
|
71.71 | 13.46B | 516.85M | 174.11M | 217.38M | 0.87 |
|
HQY
Healthequity Inc
|
107.45 | 9.31B | 1.15B | 96.70M | -161.99M | 1.09 |
|
TEM
Tempus Ai Inc
|
59.10 | 9.31B | 640.44M | -743.28M | -206.93M | -11.29 |
Goodrx Holdings Inc Stock (GDRX) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Dec-04-24 | Initiated | Mizuho | Neutral |
| Aug-09-24 | Upgrade | Raymond James | Outperform → Strong Buy |
| May-23-24 | Upgrade | RBC Capital Mkts | Sector Perform → Outperform |
| May-16-24 | Upgrade | Raymond James | Mkt Perform → Outperform |
| Apr-10-24 | Upgrade | KeyBanc Capital Markets | Sector Weight → Overweight |
| Mar-25-24 | Upgrade | Wells Fargo | Equal Weight → Overweight |
| Mar-01-24 | Upgrade | JP Morgan | Neutral → Overweight |
| Feb-26-24 | Initiated | Leerink Partners | Outperform |
| Jan-02-24 | Downgrade | BofA Securities | Buy → Underperform |
| Aug-10-23 | Upgrade | DA Davidson | Neutral → Buy |
| Jul-31-23 | Upgrade | TD Cowen | Market Perform → Outperform |
| Dec-01-22 | Initiated | Citigroup | Buy |
| Nov-04-22 | Upgrade | JP Morgan | Underweight → Neutral |
| Sep-16-22 | Initiated | KeyBanc Capital Markets | Sector Weight |
| Sep-07-22 | Initiated | Truist | Hold |
| Aug-12-22 | Initiated | DA Davidson | Neutral |
| Jun-10-22 | Downgrade | Goldman | Buy → Neutral |
| Jun-06-22 | Resumed | BofA Securities | Buy |
| Jun-01-22 | Downgrade | Robert W. Baird | Outperform → Neutral |
| May-10-22 | Downgrade | Evercore ISI | Outperform → In-line |
| May-10-22 | Downgrade | RBC Capital Mkts | Outperform → Sector Perform |
| May-10-22 | Downgrade | Raymond James | Outperform → Mkt Perform |
| May-10-22 | Downgrade | SVB Leerink | Outperform → Mkt Perform |
| Apr-11-22 | Initiated | Wells Fargo | Equal Weight |
| Apr-07-22 | Initiated | Guggenheim | Buy |
| Apr-01-22 | Resumed | Credit Suisse | Neutral |
| Mar-15-22 | Upgrade | Robert W. Baird | Neutral → Outperform |
| Mar-01-22 | Reiterated | Barclays | Overweight |
| Mar-01-22 | Reiterated | BofA Securities | Neutral |
| Mar-01-22 | Downgrade | Cowen | Outperform → Market Perform |
| Mar-01-22 | Downgrade | Credit Suisse | Outperform → Neutral |
| Mar-01-22 | Reiterated | Evercore ISI | Outperform |
| Mar-01-22 | Reiterated | Goldman | Buy |
| Mar-01-22 | Reiterated | JP Morgan | Underweight |
| Mar-01-22 | Reiterated | RBC Capital Mkts | Outperform |
| Mar-01-22 | Reiterated | SVB Leerink | Outperform |
| Jan-07-22 | Initiated | Goldman | Buy |
| Dec-21-21 | Initiated | Stephens | Overweight |
| Dec-02-21 | Initiated | Jefferies | Buy |
| Aug-31-21 | Upgrade | Barclays | Equal Weight → Overweight |
| Aug-13-21 | Upgrade | Raymond James | Mkt Perform → Outperform |
| May-28-21 | Initiated | Robert W. Baird | Neutral |
| Apr-06-21 | Resumed | Evercore ISI | Outperform |
| Jan-25-21 | Initiated | Guggenheim | Buy |
| Nov-19-20 | Upgrade | RBC Capital Mkts | Sector Perform → Outperform |
| Nov-18-20 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Oct-19-20 | Initiated | Barclays | Equal Weight |
| Oct-19-20 | Initiated | BofA Securities | Neutral |
| Oct-19-20 | Initiated | Citigroup | Buy |
| Oct-19-20 | Initiated | Cowen | Outperform |
| Oct-19-20 | Initiated | Credit Suisse | Outperform |
| Oct-19-20 | Initiated | Deutsche Bank | Hold |
| Oct-19-20 | Initiated | Goldman | Neutral |
| Oct-19-20 | Initiated | JP Morgan | Neutral |
| Oct-19-20 | Initiated | Morgan Stanley | Overweight |
| Oct-19-20 | Initiated | RBC Capital Mkts | Sector Perform |
| Oct-19-20 | Initiated | SVB Leerink | Outperform |
| Oct-19-20 | Initiated | UBS | Buy |
View All
Goodrx Holdings Inc Stock (GDRX) Latest News
GoodRx's SWOT analysis: prescription savings leader faces pharmacy headwinds - Investing.com
Insights Into GoodRx (GDRX) Q4: Wall Street Projections for Key Metrics - MSN
GoodRx Holdings Inc expected to post earnings of 10 cents a shareEarnings Preview - TradingView
GoodRx Target of Unusually High Options Trading (NASDAQ:GDRX) - Defense World
Truist Securities Reiterates Hold Rating on GoodRx Holdings Inc. (GDRX) - StreetInsider.com
Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of June 21, 2024 in GoodRx LawsuitGDRX - ACCESS Newswire
GDRX DEADLINE ALERT: Bernstein Liebhard LLP Reminds GoodRx Holdings, Inc. Investors of Upcoming Deadline - ACCESS Newswire
GoodRx (GDRX) to Release Quarterly Earnings on Thursday - Defense World
Scott Wagner Appointed to GoodRx Board of Directors - The Healthcare Technology Report.
GoodRx Holdings, Inc. Securities Fraud Class Action Lawsuit Pending: Contact Levi & Korsinsky Before June 21, 2024 to Discuss Your RightsGDRX - ACCESS Newswire
GoodRx Holdings, Inc. (NASDAQ:GDRX) Receives $8.38 Consensus Target Price from Analysts - MarketBeat
Taking a look at what insiders are doing to gauge the GoodRx Holdings Inc (GDRX)’s direction - Knox Daily
IMC Chicago LLC Makes New Investment in GoodRx Holdings, Inc. (NASDAQ:GDRX) - Defense World
High Growth Tech Stocks in United States to Watch - Simply Wall St
Take off with GoodRx Holdings Inc (GDRX): Get ready for trading - SETE News
Analysts review GoodRx Holdings Inc’s rating - Knox Daily
DEADLINE ACTION NOTICE: The Schall Law Firm Encourages Investors in GoodRx Holdings, Inc. with Losses to Contact the Firm - ACCESS Newswire
Stock Performance Spotlight: GoodRx Holdings Inc (GDRX) Ends the Day at 4.78, Down by -0.83 - The Dwinnex
How to interpret GoodRx Holdings Inc (GDRX)’s stock chart patterns - US Post News
GoodRx Holdings Inc (GDRX) Stock Price and Analyst Predictions - The News Heater
GoodRx Appoints Christopher A. McGinnis as Chief Financial Officer -February 05, 2025 at 04:05 pm EST - Marketscreener.com
GoodRx appoints CitizensRx's CEO as its new CFO - MSN
GoodRx Names Christopher McGinnis as CFO -February 05, 2025 at 05:13 pm EST - Marketscreener.com
Taking a Closer Look At GoodRx Holdings Inc (GDRX) Following Its Recent Trade - Knox Daily
GoodRx Holdings Appoints Christopher McGinnis as CFO - TipRanks
GoodRx Holdings, Inc. (GDRX) Appoints Christopher A. McGinnis as CFO - StreetInsider.com
GoodRx Strengthens Leadership: 30-Year Healthcare Finance Expert Takes CFO Helm - StockTitan
A new trading data show GoodRx Holdings Inc (GDRX) is showing positive returns. - SETE News
GoodRx (NASDAQ:GDRX) Shares Gap DownHere's Why - MarketBeat
JPMorgan Chase & Co. Has $169,000 Stake in GoodRx Holdings, Inc. (NASDAQ:GDRX) - Defense World
GoodRx Announces Date for Fourth Quarter and Full Year 2024 Earnings Release and Conference Call - Business Wire
Telemedicine GoodRx Has Potential To Excel, Close Valuation Gap By 2025, Analyst Says - MSN
GoodRx Q4 Earnings Call: Key Financial Revelations Coming February 27Mark Your Calendar - StockTitan
3 US Penny Stocks With Market Caps Over $300M To Watch - Simply Wall St
Is GoodRx Holdings (GDRX) the Best Affordable Stock Under $5 to Buy Now? - Insider Monkey
GoodRx Adds Pet Program - Los Angeles Business Journal
10 Best Affordable Stocks Under $5 to Buy Now - Insider Monkey
Millennium Management LLC Reduces Stake in GoodRx Holdings Inc - GuruFocus.com
GoodRx appoints Scott Wagner as new board director - MSN
Assenagon Asset Management S.A. Reduces Holdings in GoodRx Holdings, Inc. (NASDAQ:GDRX) - MarketBeat
GoodRx, PBMs Sued Over Alleged Generics Price-Fix Scheme - Law360
Scott Wagner appointed Co-Chair of GoodRx Board - Investing.com
GoodRx Appoints Former Interim CEO Scott Wagner as Board Co-Chair, Bringing GoDaddy Success Story - StockTitan
Short Interest in GoodRx Holdings, Inc. (NASDAQ:GDRX) Declines By 5.8% - MarketBeat
GoodRx Holdings, Inc. Announces CFO Changes, Effective January 17, 2025 - Marketscreener.com
GoodRx Holdings, Inc. (NASDAQ:GDRX) Receives Average Rating of "Moderate Buy" from Analysts - MarketBeat
GoodRx Holdings, Inc. (NASDAQ:GDRX) Receives Consensus Recommendation of “Moderate Buy” from Analysts - Defense World
Barclays PLC Grows Position in GoodRx Holdings, Inc. (NASDAQ:GDRX) - Defense World
GoodRx Holdings, Inc. (NASDAQ:GDRX) Shares Acquired by Barclays PLC - MarketBeat
GoodRx Holdings announces CFO resignation; shares drop - MSN
GoodRx (NASDAQ:GDRX) Stock Price Down 8.4% Following Analyst Downgrade - Defense World
Goodrx Holdings Inc Stock (GDRX) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.22%
0.08%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):